New Delhi, Dec 25 (IANS)With GST reforms and Research Development Incentive (RDI) Scheme, the year 2025 has been a crucial turning point for Indian pharma, said industry experts on Thursday, while highlighting innovation and increased access as key factors for the sector’s growth in 2026.Indian pharma is standing at a defining moment. In the past 25 years, the industry has grown from $3 billion to $60 billion. The next 25 years will be shaped by innovation, quality, and access.“The year 2025…
Trending
- Sheena Chohan Exclusive: From Global Cinema to Human Rights Advocacy, The Actress Redefining Purpose-Driven Stardom
- Lo Naveena Review: Humour, Heartbreak, and Friendship Shine in This Charming Kannada Entertainer
- Sattendru Maarudhu Vaanilai Review: Jai and Meenakshi Govindarajan Deliver a Wildly Entertaining Tamil Thriller You Cannot Miss
- Shikhandi (2026) Review: A Riveting Paranormal Thriller That Awakens Ancient Legends
- Sherr (2026) Movie Review: A Raw Kannada Crime Drama That Packs a Punch
- Mr. Work From Home Review: Trigun’s Bold Leap From Silicon Valley to Soil Strikes a Meaningful Chord
- Harudu (2026) Review: Venkat’s Gritty Cop Drama Delivers Raw Action and Solid Entertainment
- Kartavya Review: Saif Ali Khan Delivers a Gripping Performance in This Bold Caste-Crime Thriller on Netflix